Skip to main content
. 2018 May 29;9(41):26543–26555. doi: 10.18632/oncotarget.25489

Figure 4. Quantification of NPM-ALK in ALCL patients.

Figure 4

NPM-ALK fusion RNA, DNA and ctDNA copies in 3 ALCL patients during their disease course. (AM… course of dexamethasone, methotrexate, ifosfamide, cytarabine and etoposide; BM… course of dexamethasone, methotrexate, cyclophosphamide and doxorubicine).